According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings (TTM) are -โฌ19.53 M. In 2023 the company made an earning of -โฌ10.47 M an increase over its 2022 earnings that were of -โฌ17.95 M.The earnings displayed on this page is the company's Pretax Income.